ASP Isotopes price to sales ratio ASPI
Market value divided by revenue over the last twelve months, since 2024.
- Today, Oct 23, 2026
- 9.7×
- Peer median
- 1.8×
ASP Isotopes' price to sales ratio is 9.7× as of Oct 23, 2026.
The median for 10 chemicals stocks of a similar size is 1.8×.
Price to sales ratio over time
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 9.7× | 9.7× | 112× |
| 2025 | 76.2× | 76.2× | 198× |
| 2024 | 102× | 97.1× | 176× |
Against its peers
Companies in Chemicals nearest ASP Isotopes' size, closest first, today.
| Company | Price to sales ratio |
|---|---|
| ASPIASP Isotopes | 9.7× |
| NAGENiagen Bioscience | 1.5× |
| FTKFlotek Industries | 3.0× |
| FTLFFitlife Brands | 0.8× |
| CRONCronos | 6.9× |
| ROGRogers | 2.7× |
| BTMDbiote | 0.2× |
| NGVTIngevity | 2.1× |
| IOSPInnospec | 1.3× |
| FULFuller H B | 0.8× |
| WDFCWD 40 | 4.2× |
| Peer median | 1.8× |
Where ASP Isotopes ranks
What the price to sales ratio tells you
Market value divided by revenue over the last twelve months. Useful for companies with little or no profit yet, since sales are harder to make negative than earnings.
Ignores margins entirely. A software company at 10× sales with 30% margins can be cheaper than a grocer at 1× sales with 2% margins.
More on ASP Isotopes
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.